New drug may help throat narrowing patients avoid repeat surgeries
NCT ID NCT05309616
First seen Jan 29, 2026 · Last updated Jun 19, 2026 · Updated 21 times
Summary
This study tested whether the drug Taltz can slow scar tissue growth in the throat, reducing the need for repeat surgeries in people with idiopathic subglottic stenosis. Ten adults with the condition received the drug, and researchers measured how long they could go between surgeries compared to before treatment. The goal was to see if blocking IL-17A could help control the disease and improve quality of life.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for IDIOPATHIC SUBGLOTTIC STENOSIS are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Yale New Haven Hospital
New Haven, Connecticut, 06520, United States
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.